The Molecular Genetics Program conducts fundamental research on the etiology, progression, prevention, detection, and treatment of cancer. The scientific foci of the group are on DNA damage, DNA repair, gene regulation, hormonal responsiveness, viral carcinogenesis, and familial cancer gene identification.. The 31 member5 group has weekly data presentation meetings, mini-symposia, and annual poster sessions in addition to the weekly Cancer Center Grand Rounds, as forums for interaction. The Molecular Genetics Program is sub-divided into four focus groups: Genetic Instability, Gene Control, Molecular Virology, and Human Cancer Center Grand Rounds, as forums for interaction. The Molecular Virology and Human Cancer Genetics. Several major cancer research discoveries have been made in the previous funding interval in this Program. Important new strides have been made in defining how DNA damage is repaired. Insights from this are important in understanding how chromosomal instability permits cancers to diversity as part of their progression. The Molecular Genetics Program members have discovered cancers to diversity as part of their progression. The Molecular Genetics Program members have discovered new proteins (and their genes) that are critical to how nuclear hormone receptors function, and this is relevant to the hormonal dependence on breast and prostate cancer. Major progress has also been made in defining a novel pathway for altering gene expression by acetylation of transcription factors. Marked progress has been made in understanding the molecular basis for the persistence of hepatitis C virus, which is important to its causing hepatocellular carcinoma. Other program members are collaborating to examine breast and prostate cancers for mutations in the newly described nuclear hormone receptor mentioned above. Genetic linkage analysis of prostate cancer families is underway, and is integrated into an international consortium. The analysis of prostate cancer families is underway, and is integrated into an international consortium. The Molecular Genetics Program members have been successful in developing or participating in program project grants in gene therapy and DNA repair as a result of the fruitful scientific interaction fostered by this Program. Hence, both scientific collaborations and cancer research discoveries are facilitated by the existence of the Molecular Genetics Program.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014089-27
Application #
6563671
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2001-12-01
Project End
2002-11-30
Budget Start
Budget End
Support Year
27
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90033
McDonnell, Kevin J; Chemler, Joseph A; Bartels, Phillip L et al. (2018) A human MUTYH variant linking colonic polyposis to redox degradation of the [4Fe4S]2+ cluster. Nat Chem 10:873-880
Schirripa, Marta; Zhang, Wu; Yang, Dongyun et al. (2018) NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients. PLoS One 13:e0193640
Ryser, Marc D; Min, Byung-Hoon; Siegmund, Kimberly D et al. (2018) Spatial mutation patterns as markers of early colorectal tumor cell mobility. Proc Natl Acad Sci U S A 115:5774-5779
Rhie, Suhn Kyong; Schreiner, Shannon; Farnham, Peggy J (2018) Defining Regulatory Elements in the Human Genome Using Nucleosome Occupancy and Methylome Sequencing (NOMe-Seq). Methods Mol Biol 1766:209-229
Zhou, Beiyun; Flodby, Per; Luo, Jiao et al. (2018) Claudin-18-mediated YAP activity regulates lung stem and progenitor cell homeostasis and tumorigenesis. J Clin Invest 128:970-984
Nguyen, Lisa; Wang, Zheng; Chowdhury, Adnan Y et al. (2018) Functional compensation between hematopoietic stem cell clones in vivo. EMBO Rep 19:
Jadvar, Hossein; Chen, Xiaoyuan; Cai, Weibo et al. (2018) Radiotheranostics in Cancer Diagnosis and Management. Radiology 286:388-400
Tokunaga, Ryuma; Zhang, Wu; Naseem, Madiha et al. (2018) CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy. Cancer Treat Rev 63:40-47
McSkane, Michelle; Stintzing, Sebastian; Heinemann, Volker et al. (2018) Association Between Height and Clinical Outcome in Metastatic Colorectal Cancer Patients Enrolled Onto a Randomized Phase 3 Clinical Trial: Data From the FIRE-3 Study. Clin Colorectal Cancer 17:215-222.e3
Khanova, Elena; Wu, Raymond; Wang, Wen et al. (2018) Pyroptosis by caspase11/4-gasdermin-D pathway in alcoholic hepatitis in mice and patients. Hepatology 67:1737-1753

Showing the most recent 10 out of 842 publications